摘要
目前临床上免疫检查点抑制剂(ICI)应用广泛,常见的不良反应包括皮肤、胃肠道、内分泌和肝脏不良反应,肺脏和心脏不良反应相对较少,但可能致命。类固醇全身治疗是对抗免疫治疗相关不良反应(irAE)的主要治疗手段,如对类固醇治疗没有反应,则需要考虑使用免疫调节剂。掌握irAE的发生率、发病机制、常见类型及其治疗策略,可为ICI在临床上的安全应用提供理论依据。
At present,immune checkpoint inhibitors(ICIs)are widely used in clinical,and the common adverse reactions include adverse reactions of skin,gastrointestinal tract,endocrine and liver.Adverse reactions to the lungs and heart are relatively rare,but can be fatal.Systemic steroid therapy is the main treatment for immune related adverse events(irAEs).If there is no response to steroid therapy,an immunomodulator may be considered.Understanding the incidence,pathogenesis,common types and treatment strategies of irAEs can provide theoretical basis for the safe application of ICIs in clinical practice.
作者
李慧
杨宇
Li Hui;Yang Yu(Department of Oncology,Second Affiliated Hospital of Harbin Medical University,Harbin 150000,China)
出处
《国际肿瘤学杂志》
CAS
2021年第2期105-108,共4页
Journal of International Oncology
